Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2009 Sep;12(5):491-3.

[Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease]

[Article in Chinese]
Affiliations
  • PMID: 19742342
Randomized Controlled Trial

[Maintenance effect of polyglycosides of Tripterygium wilfordii on remission in postoperative Crohn disease]

[Article in Chinese]
Qing-song Tao et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2009 Sep.

Abstract

Objective: To observe the maintenance effect of polyglycosides of Tripterygium wilfordii (GTW) on remission in postoperative Crohn disease (CD).

Methods: From 2005 to 2007, 45 adult cases of postoperative Crohn disease were randomly divided into two groups, GTW group and mesalazine group, which received GTW and mesalazine treatment respectively. CD activity index (CDAI) and clinical markers were collected at 0, 3, 6, 12 months or at the onset of symptoms. Ileocolonoscopy was performed at the end of the trial (1 year after operation) or at the onset of symptoms, and recurrence score were recorded.

Results: No clinical recurrence was ascertained in both groups at 3 months. Four patients (18.2%) in GTW group relapsed and 5 (21.7%) in mesalazine group relapsed at 6 months (P=0.530). Seven patients (31.8%) in GTW group and 9 (39.1%) in mesalazine group relapsed at one year (P=0.421). Ten patients (45.5%) in GTW group had endoscopic recurrence compared with 14 (60.9%) in mesalazine group at one year(P=0.231). There were no significant differences between two groups.

Conclusion: GTW is similar to mesalazine in maintenance of remission of postoperative Crohn disease.

PubMed Disclaimer

Publication types